Eine klinische Studie zu Molnupiravir zur Vorbeugung schwerer Erkrankungen durch die Coronavirus-Krankheit 2019 (COVID-19) bei Menschen mit hohem Risiko (MK-4482-023) (MOVe-NOW)
Eine randomisierte, placebokontrollierte, doppelblinde klinische Phase-3-Studie zur Bewertung der Wirksamkeit und Sicherheit von Molnupiravir (MK-4482) bei nicht hospitalisierten Erwachsenen mit COVID-19 und einem hohen Risiko für das Fortschreiten der Krankheit
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health conditions or other factors have a high risk (chance) of getting severely ill from COVID-19, which can require a hospital stay or lead to death. Some people who are high risk for severe illness may be unable to take certain treatments for COVID-19 because they are not available to them, or they take other medicines that may react with a treatment and cause an unwanted effect.
Molnupiravir (MK-4482) is a study medicine designed to stop the COVID-19 virus from copying itself in the body (multiplying). The goal of this study is to learn if molnupiravir prevents severe illness from COVID-19 more than placebo in people who are high risk.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Phase 3
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Toll Free Number
- Telefonnummer: 1-888-577-8839
- E-Mail: Trialsites@msd.com
Studienorte
-
-
Buenos Aires
-
Buenos Aires., Buenos Aires, Argentinien, C1431FWO
- Rekrutierung
- CEMIC ( Site 0101)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +54-911-36115955
-
Ciudad Autonoma de Buenos Aires., Buenos Aires, Argentinien, C1199ABB
- Rekrutierung
- Hospital Italiano de Buenos Aires ( Site 0107)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +54-911-36115955
-
Mar del Plata, Buenos Aires, Argentinien, B7600FZO
- Rekrutierung
- Instituto de Investigaciones Clinicas Mar del Plata ( Site 0111)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +542234963224
-
Morón, Buenos Aires, Argentinien, 1708
- Rekrutierung
- Nefra Medical Care - Moron ( Site 0109)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +541146291083
-
-
-
-
-
São Paulo, Brasilien, 05403-010
- Rekrutierung
- Centro de Pesquisa Clinica Institucional do HCFMUSP - CPCi ( Site 0403)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +55 11 2661-7214
-
-
Amazonas
-
Manaus, Amazonas, Brasilien, 69040-000
- Rekrutierung
- Fundaçao de Medicina Tropical Doutor Heitor Vieira Dourado ( Site 0404)
-
Kontakt:
- Study Coordinator
- Telefonnummer: (92) 2127-3589
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brasilien, 30180-080
- Abgeschlossen
- Hospital Felicio Rocho (HFR) - Nucleo de Ciencias da Saude ( Site 0402)
-
-
Rio Grande do Norte
-
Natal, Rio Grande do Norte, Brasilien, 59020-500
- Rekrutierung
- Instituto Atena de Pesquisa Clinica ( Site 0406)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +558420203430
-
-
Rondônia
-
Porto Velho, Rondônia, Brasilien, 76812329
- Rekrutierung
- Centro de Pesquisa em Medicina Tropical - CEPEM - Rondonia ( Site 0405)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +556932196012
-
-
São Paulo
-
Campinas, São Paulo, Brasilien, 13060-803
- Rekrutierung
- Centro de Pesquisa Sao Lucas ( Site 0401)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +55 019997718356
-
-
-
-
-
Burgas, Bulgarien, 8000
- Rekrutierung
- Medical Center 'Medconsult' Burgas EOOD ( Site 0510)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +359879886842
-
Lovech, Bulgarien, 5500
- Rekrutierung
- Medconsult Pleven - Lovech ( Site 0501)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +35968629195
-
Montana, Bulgarien, 3400
- Rekrutierung
- Medical Center Hera ( Site 0507)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +35032261110
-
Montana, Bulgarien, 3403
- Rekrutierung
- MHAT "Dr. Stamen Iliev" Montana-Department of Pulmonology ( Site 0504)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +35996306881
-
Pleven, Bulgarien, 5800
- Rekrutierung
- Medconsult Pleven ( Site 0503)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +35964910999
-
Plovdiv, Bulgarien, 4023
- Rekrutierung
- DKC V - Plovdiv ( Site 0508)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 032261110
-
Rousse, Bulgarien, 7002
- Rekrutierung
- SHATPPD Dr. Dimitar Gramatikov - Ruse EOOD ( Site 0502)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +35982813961
-
Sofia, Bulgarien, 1510
- Rekrutierung
- Medical Center Hera EOOD ( Site 0505)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 359882441433
-
Sofia, Bulgarien, 1113
- Rekrutierung
- Diagnostic Consultative Center 22 - Sofia ( Site 0500)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +3528929840
-
Varna, Bulgarien, 9020
- Rekrutierung
- Medical Centre Pratia Clinic EOOD ( Site 0511)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +359882655182
-
-
Pazardzhik
-
Velingrad, Pazardzhik, Bulgarien, 4600
- Rekrutierung
- Medical Center Asclepius ( Site 0506)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +35935952561
-
-
Vratsa
-
Kozloduy, Vratsa, Bulgarien, 3320
- Rekrutierung
- Medical Center Zdrave 1 ( Site 0509)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +359878619077
-
-
-
-
Bavaria
-
Munich, Bavaria, Deutschland, 81675
- Rekrutierung
- TUM Klinikum ( Site 1502)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 00498941406323
-
-
Hesse
-
Frankfurt am Main, Hesse, Deutschland, 60590
- Abgeschlossen
- Universitätsklinikum Frankfurt Goethe-Universität ( Site 1503)
-
-
North Rhine-Westphalia
-
Cologne, North Rhine-Westphalia, Deutschland, 50937
- Rekrutierung
- Universitaetsklinikum Koeln ( Site 1505)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 004922147839680
-
-
State of Berlin
-
Berlin, State of Berlin, Deutschland, 10117
- Abgeschlossen
- Campus Charite Mitte Nephrologie und Internistische Intensivmedizin ( Site 1501)
-
-
-
-
Uusimaa
-
Helsinki, Uusimaa, Finnland, 00290
- Rekrutierung
- MeVac - Meilahti Vaccine Research Center ( Site 1200)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +358504270446
-
-
-
-
Bourgogne-Franche-Comté
-
Dijon, Bourgogne-Franche-Comté, Frankreich, 21000
- Rekrutierung
- Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital F-Centre d'Investigation Clinique - Plur ( Site 1301)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 3380295920
-
-
Pays de la Loire Region
-
Saint Priest En Jarez, Pays de la Loire Region, Frankreich, 42270
- Rekrutierung
- CHU de Saint-Etienne ( Site 1302)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +33477120587
-
-
Rhone
-
Pierre-Bénite, Rhone, Frankreich, 69310
- Rekrutierung
- centre hospitalier lyon sud ( Site 1303)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +33771581547
-
-
Île-de-France Region
-
Paris, Île-de-France Region, Frankreich, 75013
- Abgeschlossen
- Pitie Salpetriere University Hospital-Infectious Disease - Tropical Diseases ( Site 1300)
-
-
-
-
-
Tbilisi, Georgia, 0186
- Rekrutierung
- Curatio Clinic - Main Location ( Site 1401)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995 32 243 01 01
-
Tbilisi, Georgia, 0114
- Rekrutierung
- New Hospitals ( Site 1409)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995 322 190 190
-
-
Adjara
-
Batumi, Adjara, Georgia, 6000
- Rekrutierung
- Clinic Health - Batumi ( Site 1405)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995591409090
-
Batumi, Adjara, Georgia, 6010
- Rekrutierung
- LTD High Technology Hospital Medcenter ( Site 1408)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995596226060
-
Batumi, Adjara, Georgia, 6010
- Rekrutierung
- University Clinic of Innovative Medicine ( Site 1400)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995 422 25 20 08
-
Batumi, Adjara, Georgia, 6000
- Suspendiert
- Family Medical Regional Center ( Site 1404)
-
Tbilisi, Adjara, Georgia, 0186
- Rekrutierung
- Caucasus Medical Centre ( Site 1406)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995322600600
-
-
Samegrelo and Zemo Svaneti
-
Zugdidi, Samegrelo and Zemo Svaneti, Georgia, 2100
- Rekrutierung
- "Georgian Clinics" JSC ( Site 1410)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +995577733383
-
-
-
-
-
Bologna, Italien, 40138
- Rekrutierung
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1904)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +390512143977
-
Genova, Italien, 16132
- Rekrutierung
- Ospedale San Martino ( Site 1900)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +390105554667
-
Milan, Italien, 20157
- Rekrutierung
- ASST Fatebenefratelli Sacco ( Site 1901)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +390239042676
-
Pisa, Italien, 56124
- Rekrutierung
- AOU Pisana- Ospedale Cisanello ( Site 1905)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 39050955431
-
-
-
-
-
Fukuoka, Japan, 810-8563
- Rekrutierung
- National Hospital Organization Kyushu Medical Center ( Site 2006)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +81-92-852-0700
-
Kumamoto, Japan, 862-0965
- Rekrutierung
- Kumamoto Chuo Hospital ( Site 2002)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +81-96-370-3111
-
-
Chiba
-
Yotsukaidō, Chiba, Japan, 284-0003
- Rekrutierung
- National Hospital Organization Shimoshizu National Hospital ( Site 2007)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +81-43-422-2511
-
-
Ibaraki
-
Tsuchiura, Ibaraki, Japan, 300-0062
- Rekrutierung
- Tsuchiura Beryl Clinic ( Site 2009)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +81-29-835-3002
-
-
Tokyo
-
Kiyose, Tokyo, Japan, 204-8585
- Rekrutierung
- National Hospital Organization Tokyo National Hospital ( Site 2003)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +81-42-491-2111
-
Toshimaku, Tokyo, Japan, 171-0014
- Rekrutierung
- Sekino Hospital ( Site 2016)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +81-3-3986-5501
-
-
-
-
Antioquia
-
Medellín, Antioquia, Kolumbien, 50016
- Rekrutierung
- IPS SURA San Diego ( Site 0806)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +573183399032
-
-
Atlántico
-
Barranquilla, Atlántico, Kolumbien, 080020
- Rekrutierung
- IPS Centro Científico Asistencial S.A.S ( Site 0800)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +576053485939
-
-
Bogota D.C.
-
Bogotá, Bogota D.C., Kolumbien, 111321
- Rekrutierung
- Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 0804)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +576015948650
-
Bogotá, Bogota D.C., Kolumbien, 110111
- Abgeschlossen
- Clinica Colsanitas - Sede Reina Sofia ( Site 0807)
-
-
Cesar Department
-
Valledupar, Cesar Department, Kolumbien, 200001
- Rekrutierung
- Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0801)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 573015371818
-
-
Departamento de Córdoba
-
Montería, Departamento de Córdoba, Kolumbien, 230002
- Rekrutierung
- IMAT S.A.S ( Site 0805)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 3135342052
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, Kolumbien, 760032
- Rekrutierung
- Fundación Valle del Lili ( Site 0803)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 57 602 3319090x4022
-
-
-
-
-
Chihuahua City, Mexiko, 31000
- Rekrutierung
- ICARO Investigaciones en Medicina ( Site 2200)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +526144106319
-
Veracruz, Mexiko, 91910
- Rekrutierung
- Arké SMO S.A de C.V-ARKE SMO S.A. de C.V. ( Site 2210)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +522295896765
-
-
Guanajuato
-
León, Guanajuato, Mexiko, 37000
- Rekrutierung
- Morales Vargas Centro de Investigacion S. C. ( Site 2206)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +52 477 716 0714
-
-
Jalisco
-
Guadalajara, Jalisco, Mexiko, 44630
- Rekrutierung
- CIO - Centro de Inmuno-Oncología de Occidente ( Site 2207)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +523330447001
-
-
Mexico City
-
Mexico City, Mexico City, Mexiko, 14080
- Rekrutierung
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran-Departamento de Infectología ( Site 2203)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +52525554870900
-
-
Morelos
-
Cuernavaca, Morelos, Mexiko, 62100
- Rekrutierung
- Instituto Nacional de Salud Publica ( Site 2205)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +52 777 102 84 44
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexiko, 64460
- Rekrutierung
- Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Infectologia ( Site 2204)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +52 8181230812
-
-
Yucatán
-
Mérida, Yucatán, Mexiko, 97130
- Rekrutierung
- Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan ( Site 2202)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +529991929912
-
-
-
-
-
Auckland, Neuseeland, 1010
- Rekrutierung
- Optimal Clinical Trials ( Site 2306)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +64800737327
-
Auckland, Neuseeland, 0600
- Rekrutierung
- Pacific Clinical Research Network West Auckland ( Site 2301)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +6498830123
-
Auckland, Neuseeland, 0932
- Rekrutierung
- Silverdale Medical Limited ( Site 2305)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +6494279997
-
Auckland, Neuseeland, 0627
- Rekrutierung
- Optimal Clinical Trials North ( Site 2308)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +64800737327
-
-
Canterbury
-
Christchurch, Canterbury, Neuseeland, 8013
- Abgeschlossen
- CGM Research Trust ( Site 2307)
-
-
Tasman District
-
Nelson, Tasman District, Neuseeland, 7011
- Rekrutierung
- Pacific Clinical Research Network - Tasman ( Site 2304)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +64211448740
-
-
Waikato Region
-
Nawton, Waikato Region, Neuseeland, 3200
- Rekrutierung
- Lakeland Clinical Trials Waikato ( Site 2302)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +64273415595
-
-
Wellington Region
-
Upper Hutt, Wellington Region, Neuseeland, 5018
- Rekrutierung
- Lakeland Clinical Trials Wellington ( Site 2303)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +6449201800
-
-
-
-
-
Lima, Peru, 15036
- Rekrutierung
- Clinica Ricardo Palma-Centro de Investigacion de Enfermedades Respiratorias Thorax ( Site 2404)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 012253445
-
Lima, Peru, 15001
- Rekrutierung
- Via Libre ( Site 2409)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +5112030099
-
-
Loreto
-
Iquitos, Loreto, Peru, 16001
- Rekrutierung
- Asociación Civil Selva Amazónica ( Site 2405)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +51980463994
-
-
-
-
Cavite
-
Bacoor, Cavite, Philippinen, 4102
- Rekrutierung
- Health Index Multispeciality Clinic ( Site 2501)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 639338190062
-
-
National Capital Region
-
Makati City, National Capital Region, Philippinen, 1218
- Rekrutierung
- Ospital Ng Makati ( Site 2505)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +63288810983
-
Manila, National Capital Region, Philippinen, 1000
- Rekrutierung
- Philippine General Hospital-Department of Medicine ( Site 2504)
-
Kontakt:
- Study Coordinator
- Telefonnummer: (02) 8554 8400
-
-
Pampanga
-
San Fernando City, Pampanga, Philippinen, 2000
- Rekrutierung
- GreenCity Medical Center ( Site 2503)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 639222385026
-
-
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Polen, 60-309
- Rekrutierung
- PL Certus ( Site 2613)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 48734217034
-
-
Kuyavian-Pomeranian Voivodeship
-
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Polen, 85-048
- Rekrutierung
- In-Vivo Bydgoszcz ( Site 2601)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 48723351053
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polen, 31-322
- Rekrutierung
- NZOZ GynCentrum - Oddział Kraków ( Site 2609)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48327241012
-
-
Lower Silesian Voivodeship
-
Wroclaw, Lower Silesian Voivodeship, Polen, 54-239
- Rekrutierung
- Penta Hospitals Przychodnie Wrocław Wejherowska ( Site 2611)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 48713957541
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polen, 03-291
- Rekrutierung
- Futuremeds Targowek ( Site 2619)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48502921680
-
Warsaw, Masovian Voivodeship, Polen, 02-793
- Rekrutierung
- MCM Polimedica ( Site 2620)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48575000824
-
-
Pomeranian Voivodeship
-
Gdynia, Pomeranian Voivodeship, Polen, 81-384
- Rekrutierung
- FutureMeds Gdynia ( Site 2621)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48585065410
-
-
Silesian Voivodeship
-
Bielsko-Biala, Silesian Voivodeship, Polen, 43-300
- Rekrutierung
- NZOZ GynCentrum - Oddział Bielsko-Biała ( Site 2602)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48327241012
-
Katowice, Silesian Voivodeship, Polen, 40-156
- Rekrutierung
- Clinical Medical Research ( Site 2604)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48327248013
-
Katowice, Silesian Voivodeship, Polen, 40-600
- Rekrutierung
- Holsamed ( Site 2603)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48327241012
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, Polen, 91-363
- Rekrutierung
- Centrum Medyczne FutureMeds ( Site 2615)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +48530546417
-
-
-
-
-
Humacao, Puerto Rico, 00791
- Rekrutierung
- Investigadores del Este LLC ( Site 4001)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 787 656 0161
-
San Juan, Puerto Rico, 00921
- Rekrutierung
- Miralles Clinical Research LLC ( Site 4004)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 787 226 1014
-
San Juan, Puerto Rico, 00926
- Rekrutierung
- MV HEALTH SERVICES LLC ( Site 4003)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 787 365 2102
-
-
-
-
-
Bucharest, Rumänien, 011025
- Rekrutierung
- Centrul Medical SANA ( Site 2704)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +40212128222
-
Bucharest, Rumänien, 021105
- Rekrutierung
- National Institute for Infectious Diseases Prof. Dr. Matei Bals ( Site 2706)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +40212010980
-
Bucharest, Rumänien, 021105
- Rekrutierung
- National Institute for Infectious Diseases Prof. Dr. Matei Bals ( Site 2707)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +40212010980
-
Cluj-Napoca, Rumänien, 400348
- Rekrutierung
- Spitalul Clinic de Boli Infecțioase ( Site 2703)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +40264594655
-
Constanța, Rumänien, 900709
- Rekrutierung
- Spitalul Clinic de Boli Infecțioase ( Site 2702)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +40771696527
-
-
Bucharest
-
Bucharest, Bucharest, Rumänien, 030303
- Rekrutierung
- Spitalul Clinic de Boli Infecțioase și Tropicale Victor Babeș ( Site 2701)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +40213172727
-
-
Ilfov
-
Baloteşti, Ilfov, Rumänien, 077015
- Abgeschlossen
- Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu ( Site 2705)
-
-
-
-
-
Barcelona, Spanien, 08025
- Rekrutierung
- EAP Sardenya ( Site 3109)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34935674385
-
Madrid, Spanien, 28031
- Rekrutierung
- Hospital Universitario Infanta Leonor ( Site 3110)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 34911918280
-
Seville, Spanien, 41013
- Rekrutierung
- HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO ( Site 3100)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34697958658
-
-
Alicante
-
Elche, Alicante, Spanien, 03202
- Rekrutierung
- Hospital General Universitario de Elche-Infectius Disease ( Site 3105)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34966616754
-
-
Barcelona
-
Badalona, Barcelona, Spanien, 08916
- Rekrutierung
- Hospital Germans Trias i Pujol ( Site 3101)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34934978349
-
Centelles, Barcelona, Spanien, 08540
- Rekrutierung
- EAP Osona Sud - Alt Congost S.L.P ( Site 3107)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34938810485
-
-
Catalonia
-
Barcelona, Catalonia, Spanien, 08035
- Rekrutierung
- Hospital Universitari Vall d'Hebron ( Site 3102)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34934896090
-
-
Galicia
-
A Coruña, Galicia, Spanien, 15006
- Rekrutierung
- Hospital Universitario de A Coruña ( Site 3112)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 34 981 17 81 57
-
-
Murcia
-
Cartagena, Murcia, Spanien, 30202
- Rekrutierung
- Hospital Santa Lucia-Medicina Infecciosas ( Site 3106)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +34968110471
-
-
-
-
-
Seoul, Südkorea, 02841
- Rekrutierung
- Korea University Anam Hospital ( Site 3001)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 82-2-920-5096
-
Seoul, Südkorea, 07441
- Rekrutierung
- Hallym University Kangnam Sacred Heart Hospital-Internal Medicine ( Site 3003)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +8228295106
-
Seoul, Südkorea, 08308
- Rekrutierung
- Korea University Guro Hospital ( Site 3006)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +82226263052
-
-
Kang-won-do
-
Wŏnju, Kang-won-do, Südkorea, 26426
- Rekrutierung
- Wonju Severance Christian Hospital-Internal Medicine ( Site 3009)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +82-33-741-0519
-
-
Kwangju-Kwangyokshi
-
Gwangju, Kwangju-Kwangyokshi, Südkorea, 61469
- Rekrutierung
- Chonnam National University Hospital-Infectious Diseases ( Site 3008)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 82-62-220-6295
-
-
Kyonggi-do
-
Ansan-si, Kyonggi-do, Südkorea, 15355
- Rekrutierung
- Korea University Ansan Hospital ( Site 3007)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 82-31-412-5011
-
-
Kyongsangnam-do
-
Jinju, Kyongsangnam-do, Südkorea, 52727
- Rekrutierung
- Gyeongsang National University Hospital ( Site 3005)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +82557508055
-
-
Pusan-Kwangyokshi
-
Pusan, Pusan-Kwangyokshi, Südkorea, 49241
- Rekrutierung
- Pusan National University Hospital-Internal Medicine ( Site 3010)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +82-51-240-8592
-
-
Taegu-Kwangyokshi
-
Deagu, Taegu-Kwangyokshi, Südkorea, 41404
- Rekrutierung
- Kyungpook National University Chilgok Hospital-Division of Infectious Diseases ( Site 3002)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 82-53-200-2616
-
-
-
-
-
Kaohsiung City, Taiwan, 813
- Rekrutierung
- Kaohsiung Veterans General Hospital ( Site 3307)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +88673422121x72187
-
New Taipei City, Taiwan, 23561
- Rekrutierung
- Taipei Medical University - Shuang Ho Hospital ( Site 3308)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +88622249-0088
-
Taichung, Taiwan, 40705
- Rekrutierung
- Taichung Veterans General Hospital ( Site 3305)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +886423592525x6523
-
Taipei, Taiwan, 114
- Rekrutierung
- Tri-Service General Hospital ( Site 3304)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +886287923311x13655
-
Taipei, Taiwan, 10002
- Rekrutierung
- National Taiwan University Hospital ( Site 3301)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +886-2-2312-3456
-
Taipei, Taiwan, 11696
- Rekrutierung
- Taipei Municipal Wangfang Hospital ( Site 3309)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +886229307930
-
Taoyuan, Taiwan, 333
- Rekrutierung
- Chang Gung Memorial Hospital - Linkou Branch ( Site 3303)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +88633281200x8450
-
-
Kaohsiung
-
Kaoshiung, Kaohsiung, Taiwan, 807
- Rekrutierung
- Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 3306)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +88673121101
-
-
Taoyuan
-
Taoyuan City, Taoyuan, Taiwan, 33004
- Rekrutierung
- Taoyuan General Hospital ( Site 3300)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +88633699721x8311
-
-
-
-
Bangkok
-
Bangkok, Bangkok, Thailand, 10700
- Aktiv, nicht rekrutierend
- Faculty of Medicine Siriraj Hospital-Department of Medicine ( Site 3401)
-
Pathumwan, Bangkok, Thailand, 10330
- Aktiv, nicht rekrutierend
- HIV Netherlands Australia Thailand Research Collaboration ( Site 3402)
-
-
-
-
-
Kyiv, Ukraine, 02222
- Rekrutierung
- Medlight Clinic ( Site 3548)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +38 067 46632
-
Kyiv, Ukraine, 03049
- Rekrutierung
- Kyiv Railway Clinical Hospital No.2 of Branch Health Center -Center of Clinical Trials ( Site 3549)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380509165888
-
-
Cherkasy Oblast
-
Cherkasy, Cherkasy Oblast, Ukraine, 18021
- Rekrutierung
- EUROMEDCLINIC ( Site 3517)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380966684934
-
-
Chernivetska Oblast
-
Chernivtsi, Chernivetska Oblast, Ukraine, 58000
- Rekrutierung
- MUNICIPAL NON-PROFIT ENTERPRISE CENTRAL CITY CLINICAL HOSPITAL OF CHERNIVTSI CITY COUNCIL ( Site 3513)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 380501835097
-
-
Ivano-Frankivsk Oblast
-
Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine, 76008
- Rekrutierung
- Clinical medical and diagnostic center Limited Liability Company "Simedgroup" ( Site 3524)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380669779646
-
Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine, 76018
- Rekrutierung
- Regional Phthisiology and Pulmonology Center ( Site 3523)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380503383383
-
-
Kirovohrad Oblast
-
Kropyvnytskyi, Kirovohrad Oblast, Ukraine, 25006
- Rekrutierung
- Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 3537)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380522 366002
-
Kropyvnytskyi, Kirovohrad Oblast, Ukraine, 25011
- Rekrutierung
- Limited Liability Company Ukrainian Center of Tomotherapy-Clinical Trials Department ( Site 3512)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +38 095 8718674
-
-
Kyivska Oblast
-
Kyiv, Kyivska Oblast, Ukraine, 01135
- Rekrutierung
- Medical Center "Harmoniya Krasy" ( Site 3545)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380936306646
-
Kyiv, Kyivska Oblast, Ukraine, 04210
- Rekrutierung
- Center of Family Medicine Plus ( Site 3502)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380509084116
-
Kyiv, Kyivska Oblast, Ukraine, 02002
- Rekrutierung
- Edelweiss Medics ( Site 3503)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380504446557
-
Kyiv, Kyivska Oblast, Ukraine, 04050
- Rekrutierung
- Medical Center of Limited ( Site 3546)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380969949971
-
Kyiv, Kyivska Oblast, Ukraine, 03037
- Rekrutierung
- Medbud Clinic-Treatment prevention unit ( Site 3506)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380503572250
-
Kyiv, Kyivska Oblast, Ukraine, 02091
- Rekrutierung
- Communal Non-Profit Enterprise "Kyiv City Clinical Hospital #1"-Department of Clinical Research ( Site 3514)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +38 044 5611708
-
-
Lviv Oblast
-
Lviv, Lviv Oblast, Ukraine, 79011
- Rekrutierung
- Polyclinic of Communal 4th city clinical hospital ( Site 3501)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380504727692
-
Lviv, Lviv Oblast, Ukraine, 79059
- Suspendiert
- Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 3525)
-
-
Vinnytsia Oblast
-
Vinnytsia, Vinnytsia Oblast, Ukraine, 21001
- Rekrutierung
- University clinic of the National Pirogov Memorial Medical University ( Site 3547)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380965363123
-
Vinnytsia, Vinnytsia Oblast, Ukraine, 21029
- Rekrutierung
- Clinic of Scientific and Research Institute of Invalid Rehabilitation of VNMU n.a. M.I.Pyrohov ( Site 3528)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380673978046
-
-
Volyn Oblast
-
Lutsk, Volyn Oblast, Ukraine, 43005
- Rekrutierung
- Municipal Enterprise "Volyn Regional Clinical Hospital" of Volyn Regional Council ( Site 3530)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +380958969484
-
-
Zakarpattia Oblast
-
Uzhhorod, Zakarpattia Oblast, Ukraine, 88000
- Rekrutierung
- Uzhhorod Municipal Multidisciplinary Clinical Hospital of Uzhhorod City Council ( Site 3538)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 380664959049
-
-
-
-
Alabama
-
Cullman, Alabama, Vereinigte Staaten, 35055
- Abgeschlossen
- Cullman Clinical Trials ( Site 3813)
-
-
Arizona
-
Paradise Valley, Arizona, Vereinigte Staaten, 85253
- Rekrutierung
- Helios Clinical Research ( Site 3826)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 480-659-0448
-
Phoenix, Arizona, Vereinigte Staaten, 85051
- Abgeschlossen
- Absolute Clinical Research ( Site 3709)
-
-
California
-
Castroville, California, Vereinigte Staaten, 95012
- Rekrutierung
- Clinica de Salud del Valle de Salinas ( Site 3825)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 805-483-1185
-
Fullerton, California, Vereinigte Staaten, 92835
- Abgeschlossen
- Ascada Health PC dba Ascada Research ( Site 3750)
-
Los Alamitos, California, Vereinigte Staaten, 90720
- Rekrutierung
- Pacific Clinical Studies ( Site 3827)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 5625980600x205
-
Northridge, California, Vereinigte Staaten, 91325
- Rekrutierung
- Valley Clinical Trials, Inc. ( Site 3707)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 818-280-4220
-
Oxnard, California, Vereinigte Staaten, 93030
- Rekrutierung
- FOMAT Medical Research ( Site 3720)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 805-483-1185
-
San Diego, California, Vereinigte Staaten, 91208
- Rekrutierung
- Paradigm Clinical Research, LLC ( Site 3785)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 858274426
-
San Francisco, California, Vereinigte Staaten, 94102
- Rekrutierung
- Optimus Medical ( Site 3817)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 415-518-1292
-
Westlake Village, California, Vereinigte Staaten, 91361
- Rekrutierung
- Millennium Clinical Trials ( Site 3758)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 805-496-3322
-
-
Colorado
-
Wheat Ridge, Colorado, Vereinigte Staaten, 80033
- Rekrutierung
- Paradigm Clinical Research Centers, Inc ( Site 3718)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 303-463-1947
-
-
Florida
-
Boynton Beach, Florida, Vereinigte Staaten, 33436
- Rekrutierung
- Encore Medical Research of Boynton Beach ( Site 3701)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 561-774-8799
-
Coral Gables, Florida, Vereinigte Staaten, 33134
- Rekrutierung
- Prestige Clinical Research Center ( Site 3722)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-907-6960
-
Homestead, Florida, Vereinigte Staaten, 33030
- Rekrutierung
- Prestige Clinical Research ( Site 3830)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-907-6961
-
Largo, Florida, Vereinigte Staaten, 33777
- Rekrutierung
- Accel Research Sites Network - St. Pete-Largo Clinical Research Unit ( Site 3779)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 727-347-8839
-
Leesburg, Florida, Vereinigte Staaten, 34748
- Rekrutierung
- Clinical Site Partners, LLC dba Flourish Research ( Site 3717)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 325-435-7240
-
Loxahatchee Groves, Florida, Vereinigte Staaten, 33470
- Aktiv, nicht rekrutierend
- Advanced Pulmonary Research Institute ( Site 3781)
-
Miami, Florida, Vereinigte Staaten, 33125
- Rekrutierung
- Southern Clinical Research ( Site 3773)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 844-312-1727
-
Miami, Florida, Vereinigte Staaten, 33176
- Rekrutierung
- Reed Medical Research ( Site 3761)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-413-0531
-
Miami, Florida, Vereinigte Staaten, 33143
- Rekrutierung
- Florida Pharmaceutical Research and Associates ( Site 3763)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 786-254-7296
-
Miami, Florida, Vereinigte Staaten, 33144
- Rekrutierung
- Bio-Medical Research LLC ( Site 3804)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-671-3686
-
Miami, Florida, Vereinigte Staaten, 33155
- Rekrutierung
- Miami Clinical Research ( Site 3729)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-433-6496
-
Miami, Florida, Vereinigte Staaten, 33144
- Abgeschlossen
- Bright Research Center ( Site 3746)
-
Miami Lakes, Florida, Vereinigte Staaten, 33014
- Rekrutierung
- Panax Clinical Research ( Site 3803)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-698-4500
-
Miami Lakes, Florida, Vereinigte Staaten, 33014
- Rekrutierung
- Palm Springs Community Health Center ( Site 3757)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 786-334-6675
-
Miami Lakes, Florida, Vereinigte Staaten, 33016
- Rekrutierung
- Indago Research and Health Center Inc ( Site 3714)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 305-825-6588
-
Orlando, Florida, Vereinigte Staaten, 32807
- Rekrutierung
- Combined Research Orlando Phase I-IV ( Site 3797)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 407-440-4493
-
Port Saint Lucie, Florida, Vereinigte Staaten, 34952
- Rekrutierung
- CDC Research Institute ( Site 3716)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 772-807-1636
-
Tampa, Florida, Vereinigte Staaten, 33603
- Rekrutierung
- New Tampa Health ( Site 3764)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 813-440-6355
-
Tampa, Florida, Vereinigte Staaten, 33614
- Rekrutierung
- Precision Research Center ( Site 3704)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 813-513-2365
-
Tampa, Florida, Vereinigte Staaten, 33607
- Rekrutierung
- Clinical Research Trials of Florida ( Site 3703)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 813-873-8102
-
Weston, Florida, Vereinigte Staaten, 33331
- Abgeschlossen
- Encore Medical Research - Weston ( Site 3708)
-
-
Georgia
-
Lawrenceville, Georgia, Vereinigte Staaten, 30046
- Abgeschlossen
- Balanced Life Health Care Solutions/SKYCRNG ( Site 3713)
-
Snellville, Georgia, Vereinigte Staaten, 30078
- Rekrutierung
- Renew Health Clinical Research ( Site 3760)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 706-223-3560
-
Union City, Georgia, Vereinigte Staaten, 30291
- Abgeschlossen
- Rophe Adult and Pediatric Medicine/SKYCRNG ( Site 3816)
-
-
Idaho
-
Boise, Idaho, Vereinigte Staaten, 83709
- Abgeschlossen
- Paradigm Clinical Research - Boise ( Site 3841)
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60612
- Rekrutierung
- Rush University Medical Center ( Site 3748)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 312-942-5987
-
Lombard, Illinois, Vereinigte Staaten, 60148
- Rekrutierung
- Duly Health and Care ( Site 3799)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 630-545-7760
-
-
Kentucky
-
Louisville, Kentucky, Vereinigte Staaten, 40202
- Rekrutierung
- University of Louisville School of Medicine ( Site 3706)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 502-852-3836
-
-
Louisiana
-
Natchitoches, Louisiana, Vereinigte Staaten, 71457
- Abgeschlossen
- Barnum Medical Research ( Site 3828)
-
-
Maryland
-
Annapolis, Maryland, Vereinigte Staaten, 21401
- Rekrutierung
- Annapolis Internal Medicine - CCT Research ( Site 3700)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 410-824-1005
-
Columbia, Maryland, Vereinigte Staaten, 21045
- Rekrutierung
- Kur Research - Columbia Medical ( Site 3767)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 410-964-8522
-
-
Michigan
-
Dearborn, Michigan, Vereinigte Staaten, 48126
- Abgeschlossen
- Revival Research Institute, LLC ( Site 3835)
-
Farmington Hills, Michigan, Vereinigte Staaten, 48334
- Abgeschlossen
- Michigan Center of Medical Research (MICHMER) ( Site 3734)
-
Grosse Pointe Woods, Michigan, Vereinigte Staaten, 48236
- Rekrutierung
- Henry Ford St John TM Center for Infectious Disease Research ( Site 3766)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 313-343-6311
-
-
Minnesota
-
Mankato, Minnesota, Vereinigte Staaten, 56001
- Rekrutierung
- Mankato Clinic ( Site 3842)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 507-625-1811
-
-
Mississippi
-
Fayette, Mississippi, Vereinigte Staaten, 39069
- Abgeschlossen
- Prime Health and Wellness/SKYCRNG ( Site 3726)
-
Ridgeland, Mississippi, Vereinigte Staaten, 39157
- Rekrutierung
- SKY Integrative Medical Center/SKYCRNG ( Site 3740)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 601-617-7717
-
-
Nevada
-
Carson City, Nevada, Vereinigte Staaten, 89706
- Rekrutierung
- Nevada Health Centers ( Site 3840)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 770-200-9775
-
Las Vegas, Nevada, Vereinigte Staaten, 89106
- Rekrutierung
- WR-CRCN, LLC ( Site 3818)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 702-893-8968
-
-
New Jersey
-
Newark, New Jersey, Vereinigte Staaten, 07102
- Rekrutierung
- Saint Michael's Medical Center ( Site 3808)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 973-877-5162
-
Teaneck, New Jersey, Vereinigte Staaten, 07666
- Abgeschlossen
- Holy Name Medical Center ( Site 3807)
-
-
New York
-
New York, New York, Vereinigte Staaten, 10065
- Rekrutierung
- Weill Cornell Medical College ( Site 3814)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 212-746-7587
-
The Bronx, New York, Vereinigte Staaten, 10456
- Rekrutierung
- Prime Global Research ( Site 3731)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 718-676-9444
-
-
North Carolina
-
Charlotte, North Carolina, Vereinigte Staaten, 28277
- Rekrutierung
- OnSite Clinical Solutions ( Site 3784)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 800-785-3150
-
Monroe, North Carolina, Vereinigte Staaten, 28112
- Rekrutierung
- Monroe Biomedical Research ( Site 3732)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 704-283-7359
-
Mount Airy, North Carolina, Vereinigte Staaten, 27030
- Rekrutierung
- IMA Clinical Research Mount Airy ( Site 3745)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 336-415-5507
-
-
Ohio
-
Beavercreek, Ohio, Vereinigte Staaten, 45431
- Abgeschlossen
- Research Innovations, LLC ( Site 3712)
-
-
South Carolina
-
Columbia, South Carolina, Vereinigte Staaten, 29205
- Aktiv, nicht rekrutierend
- Midlands Neurology & Pain Associates ( Site 3751)
-
-
Tennessee
-
Jackson, Tennessee, Vereinigte Staaten, 38305
- Rekrutierung
- Helios Clinical Research - JAC ( Site 3833)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 731-431-5027
-
-
Texas
-
Conroe, Texas, Vereinigte Staaten, 77384
- Rekrutierung
- Javara - Privia Medical Group Gulf Coast - The Woodlands HWH ( Site 3837)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 281-639-5061
-
Corpus Christi, Texas, Vereinigte Staaten, 78404
- Rekrutierung
- South Texas Clinical Research ( Site 3815)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 361-288-4668
-
Forney, Texas, Vereinigte Staaten, 75126
- Aktiv, nicht rekrutierend
- Care United Research, LLC ( Site 3747)
-
Houston, Texas, Vereinigte Staaten, 77030
- Rekrutierung
- Houston Methodist Hospital ( Site 3800)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 713-441-3250
-
Houston, Texas, Vereinigte Staaten, 77030
- Rekrutierung
- MD Anderson ( Site 3843)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 713-792-6830
-
Laredo, Texas, Vereinigte Staaten, 78041
- Rekrutierung
- Andres Garcia Zuniga, M.D., P.A. ( Site 3782)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 956-307-4280
-
Pearland, Texas, Vereinigte Staaten, 77584
- Rekrutierung
- LinQ Research ( Site 3824)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 281-916-4220
-
Victoria, Texas, Vereinigte Staaten, 77901
- Rekrutierung
- Crossroads Clinical Research-Family Practice ( Site 3739)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 361-574-7800
-
-
Virginia
-
Hampton, Virginia, Vereinigte Staaten, 23666
- Abgeschlossen
- Velocity Clinical Research - Hampton ( Site 3744)
-
-
Washington
-
Redmond, Washington, Vereinigte Staaten, 98052
- Rekrutierung
- Eastside Research Associates ( Site 3727)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 425-869-6828
-
-
-
-
Bristol, City of
-
Bristol, Bristol, City of, Vereinigtes Königreich, BS8 2PU
- Rekrutierung
- Whiteladies Medical Group ( Site 3611)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 01179731201
-
-
England
-
Exeter, England, Vereinigtes Königreich, EX2 5DW
- Rekrutierung
- Royal Devon & Exeter Hospital ( Site 3604)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 01392411611
-
-
Newcastle Upon Tyne
-
Newcastle, Newcastle Upon Tyne, Vereinigtes Königreich, NE1 4LP
- Rekrutierung
- Royal Victoria Infirmary ( Site 3608)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +441912336161
-
-
Norfolk
-
Norwich, Norfolk, Vereinigtes Königreich, NR3 3DL
- Rekrutierung
- Oak Street Medical Practice ( Site 3612)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +441603613431
-
Norwich, Norfolk, Vereinigtes Königreich, NR1 1RB
- Rekrutierung
- Norwich Practices Health Centre ( Site 3605)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +4407552431271
-
-
Northamptonshire
-
Northamptonshire, Northamptonshire, Vereinigtes Königreich, NN17 2UR
- Rekrutierung
- Lakeside Surgery ( Site 3600)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +441536748282
-
-
Oxfordshire
-
Bicester, Oxfordshire, Vereinigtes Königreich, OX26 6AT
- Rekrutierung
- Bicester Health Centre ( Site 3609)
-
Kontakt:
- Study Coordinator
- Telefonnummer: 01869 249333
-
Oxford, Oxfordshire, Vereinigtes Königreich, OX16 9AD
- Rekrutierung
- Banbury Cross Health Centre ( Site 3610)
-
Kontakt:
- Study Coordinator
-
-
Somerset
-
Somerset, Somerset, Vereinigtes Königreich, TA11 7PB
- Rekrutierung
- Buttercross Health Centre ( Site 3606)
-
Kontakt:
- Study Coordinator
- Telefonnummer: +441458272473
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria
The main inclusion criteria include but are not limited to the following:
-
Is an individual of any sex/gender, ≥18 years of age
-
Has documentation of SARS-CoV-2 infection with sample collection ≤4 days prior to randomization
-
Has initial onset of signs/symptoms attributable to COVID-19 for ≤4 days prior to the day of randomization and ≥2 of the following signs/symptoms attributable to COVID-19 on the day of randomization: cough, sore throat, nasal congestion, shortness of breath or difficulty breathing with exertion, muscle or body aches, fatigue, fever >38.0°C or chills, nausea or vomiting or diarrhea, change in sense of smell or change in sense of taste, or headache
-
Has ≥1 of the following characteristics or medical conditions associated with the highest risk of severe illness from COVID-19:
- Advanced age of ≥75 years of age
- Immunocompromised
- Neurocognitive or physical disability
- Has ≥3 characteristics or medical conditions which increase the risk of severe illness due to COVID-19 (e.g., chronic lung disease, obesity with body mass index (BMI) ≥35, diabetes)
-
Is unable or unwilling to receive treatment with nirmatrelvir/ritonavir (NMV/r) due to 1 or more of the following:
- Is receiving drug(s) highly dependent on cytochrome P450 3A (CYP3A) for clearance and for which elevated concentrations are associated with serious and/or life-threatening consequences or drug(s) with a clinically significant drug-drug interaction for which co-administration is not possible
- Is receiving potent CYP3A inducers where significantly reduced nirmatrelvir or ritonavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance
- Has severe hepatic impairment
- Has experienced prior adverse reactions or hepatotoxicity to NMV/r that would preclude future use
- Has known or suspected NMV/r resistance
- Has uncontrolled HIV infection
- NMV/r is not approved/authorized in the participant's country or it is not accessible to participant (e.g., drug shortage)
- Is unwilling to receive treatment with NMV/r
Inclusion note: Participants may receive remdesivir as standard of care in addition to molnupiravir or placebo. If remdesivir is available and clinically appropriate per local clinical practice, investigators will aim to ensure that those who are most vulnerable to severe COVID-19 receive timely access to remdesivir as standard of care on this study.
Exclusion Criteria
The main exclusion criteria include but are not limited to the following:
-
Is currently hospitalized or is expected to need hospitalization for COVID-19 imminently
-
Has received or plans to receive SARS-CoV-2 directed oral antivirals or monoclonal antibodies for current episode of COVID-19 (other than study intervention and, if applicable, remdesivir as standard of care)
-
Has ≥1 of the following signs/symptoms that are attributable to severe or critical COVID-19:
- Shortness of breath at rest
- Respiratory rate ≥30 breaths per minute
- Heart rate ≥125 beats per minute
- Peripheral oxygen saturation (SpO2) ≤93% on room air or on supplemental oxygen for a reason other than COVID-19 which has not increased since onset of COVID-19 signs/symptoms
- New or increasing need for supplemental oxygen: receiving >4 liters/minute supplemental oxygen due to COVID-19 OR on supplemental oxygen for a reason other than COVID-19 which has increased due to COVID-19
-
Has received a COVID-19 vaccine within 30 days prior to randomization
-
Has a history of confirmed influenza, respiratory syncytial virus (RSV), or SARS-CoV-2 infection (with or without symptoms; excluding current infection) within 30 days prior to randomization
-
Has known or suspected hypersensitivity to active or inactive ingredients of molnupiravir
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Molnupiravir
Participants will receive 800 mg molnupiravir orally every 12 hours for 5 days (a total of 10 consecutive doses) |
Molnupiravir administered orally as two 400 mg film-coated tablets every 12 hours for 5 days (a total of 10 consecutive doses)
Andere Namen:
|
|
Placebo-Komparator: Placebo
Participants will receive molnupiravir-matching placebo orally every 12 hours for 5 days (a total of 10 consecutive doses) |
Molnupiravir-matching placebo administered orally as two film-coated tablets every 12 hours for 5 days (a total of 10 consecutive doses) |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Percentage of Participants Who Experienced One or More of Following Through Day 29: All-cause Hospitalization, All-cause Mortality, or Covid-19-related Medically-attended Visit (MAV)
Zeitfenster: Up to 29 days
|
Hospitalization is defined as ≥24 hours of acute care in a hospital or similar acute care facility, including emergency rooms or facilities created to address hospitalization needs specifically for COVID-19. Hospitalization and death may be due to any cause. An MAV is defined as any unscheduled, nonroutine healthcare visit where the participant is evaluated by a licensed (according to local/national guidelines) healthcare provider. As prespecified by the protocol, the percentage of participants who experience ONE OR MORE of these 3 events (hospitalization, death, or COVID-19-related MAV) occurring from randomization through Day 29 will be presented. |
Up to 29 days
|
|
Percentage of Participants Who Experienced an Adverse Event (AE)
Zeitfenster: Up to approximately 5 months
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The percentage of participants with at least 1 AE will be presented. |
Up to approximately 5 months
|
|
Percentage of Participants Who Discontinued Study Intervention Due to AE
Zeitfenster: Up to approximately 5 days
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The percentage of participants who discontinue study intervention due to an AE will be presented. |
Up to approximately 5 days
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Time to Sustained Alleviation (without relapse) of all selected 8 (5 prespecified and 3 determined by baseline prevalence), self-reported COVID-19 signs/symptoms
Zeitfenster: Up to 29 days
|
Time to sustained alleviation without relapse is defined as the number of days from randomization to the first of 2 consecutive days when alleviation (lessening of symptoms) is demonstrated, collectively, for all 8 selected COVID-19-related sign/symptoms. Participants who experience sustained alleviation for 2 consecutive days must not relapse in any of the 8 signs/symptoms before Day 29. The time to sustained alleviation without relapse of all 8 selected COVID-19-related signs/symptoms from randomization through Day 29 will be presented. |
Up to 29 days
|
|
Change from Baseline in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA Titer
Zeitfenster: Day 1 (baseline) and up to Day 29
|
SARS-CoV-2 RNA titer (viral load) will be measured by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) of samples from nasopharyngeal (NP) swabs, and the mean change from baseline will be presented. |
Day 1 (baseline) and up to Day 29
|
|
Percentage of Participants with Undetectable SARS-CoV-2 RNA
Zeitfenster: Up to 29 days
|
SARS-CoV-2 RNA (viral load) will be measured by quantitative RT-PCR of samples from NP swabs, and the percentage of participants with undetectable (i.e., below the lower limit of quantification) SARS-CoV-2 RNA (viral load) will be presented. |
Up to 29 days
|
|
Percentage of Participants Who Experienced One or More of Following Through Day 29: All-cause Hospitalization or All-cause Mortality
Zeitfenster: Up to 29 days
|
Hospitalization is defined as ≥24 hours of acute care in a hospital or similar acute care facility, including emergency rooms or facilities created to address hospitalization needs specifically for COVID-19. Hospitalization and death may be due to any cause. As prespecified by the protocol, the percentage of participants who experience hospitalization AND/OR death occurring from randomization through Day 29 will be presented. |
Up to 29 days
|
|
Percentage of Participants With Clinically Important Medical Interventions (CIMI) Associated with COVID-19-related MAV or COVID-19-related Hospitalization Through Day 29
Zeitfenster: Up to 29 days
|
CIMIs were prespecified by the protocol and include, but are not limited to, supplemental oxygen therapy, IV fluid administration, and nebulizer treatment. An MAV is defined as any unscheduled, nonroutine healthcare visit where the participant is evaluated by a licensed (according to local/national guidelines) healthcare provider. Hospitalization is defined as ≥24 hours of acute care in a hospital or similar acute care facility, including emergency rooms or facilities created to address hospitalization needs specifically for COVID-19. The percentage of participants with CIMIs associated with a COVID-19-related MAV AND/OR a COVID-19-related hospitalization through Day 29 will be reported. |
Up to 29 days
|
|
Time to Sustained Alleviation (without relapse) of all 15 self-reported COVID-19 signs/symptoms through Day 29
Zeitfenster: Up to 29 days
|
Time to sustained alleviation without relapse is defined as the number of days from randomization to the first of 2 consecutive days when alleviation (lessening of symptoms) is demonstrated, collectively, for all 15 COVID-19-related sign/symptoms. Participants who experience sustained alleviation after 2 consecutive days must not relapse in any of the 15 signs/symptoms before Day 29. The time to sustained alleviation without relapse of all 15 COVID-19-related signs/symptoms from randomization through Day 29 will be presented. |
Up to 29 days
|
|
Time to Sustained Resolution Without Relapse of all 8 (5 prespecified and 3 determined by baseline prevalence) self-reported COVID-19 signs/symptoms through Day 29
Zeitfenster: Up to 29 days
|
Time to sustained resolution without relapse is defined as the number of days from randomization to the first of 2 consecutive days when resolution (having no symptoms or only mild symptoms) is demonstrated, collectively, for all 8 selected COVID-19-related sign/symptoms. Participants who experience sustained resolution after 2 consecutive days must not relapse in any of the 8 signs/symptoms before Day 29. The time to sustained resolution without relapse of all 8 selected COVID-19-related signs/symptoms from randomization through Day 29 will be presented. |
Up to 29 days
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Studienleiter: Medical Director, Merck Sharp & Dohme LLC
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 4482-023
- U1111-1295-4678 (Registrierungskennung: UTN)
- MK-4482-023 (Andere Kennung: MSD)
- 2023-507227-36-00 (Registrierungskennung: EU CT)
- jRCT2031250022 (Registrierungskennung: Japan Registry of Clinical Trials (jRCT))
- 2023 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .